Phase I trial of 2B1, a bispecific monoclonal antibody targeting c-erbB-2 and Fc gamma RIII.
1995 · PubMed · 140 citations
M
Michael P. Davey
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
85
Papers
3.6K
Citations
34
h-index
57
i10-index
Michael P. Davey is an academic researcher from Atlantic Cancer Research Institute. The author has contributed to research in topics: Sarcoidosis and Beryllium Toxicity Research & T-cell and B-cell Immunology & Ocular Diseases and Behçet’s Syndrome. The author has an h-index of 34, co-authored 73 publications.
ORCID: 0000-0002-8768-848XPapers by this author
worksT cell receptor V <i>beta</i> gene expression in monozygotic twins. Discordance in CD8 subset and in disease states.
1994 · The Journal of Immunology · 41 citations
https://doi.org/10.4049/jimmunol.152.1.315
T cell-intrinsic role for Nod2 in protection against Th17-mediated uveitis
2020 · Nature Communications · 33 citations
https://doi.org/10.1038/s41467-020-18961-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat